Directory

>

Peter Ordentlich

avatar

Peter Ordentlich

Chief Scientific Officer | Syndax Pharmaceuticals

Lexington, Massachusetts, United States

View contact details (it's free)

Peter Ordentlich

Summary

Peter Ordentlich is a seasoned scientific leader currently serving as the Chief Scientific Officer at Syndax Pharmaceuticals, a role he has held since November 2013. With a Ph.D. in Immunology from the University of Pennsylvania, he has built a robust career in the scientific research and development sector, contributing significantly to the field of translational medicine. Prior to his current position, Peter held various roles at Syndax and the Salk Institute, where he honed his expertise in drug development and research methodologies. His career reflects a deep commitment to advancing scientific knowledge and innovation. Peter's experience spans over two decades, showcasing his ability to lead complex research initiatives in both academic and corporate environments. He is known for his strategic vision and collaborative approach, which have been instrumental in driving scientific advancements. Outside of his professional endeavors, Peter is passionate about mentoring the next generation of scientists and fostering a culture of innovation in the pharmaceutical industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Non-Profit Experience

Peter Ordentlich

Work Experience

company logo

Chief Scientific Officer at

Syndax Pharmaceuticals

November 2013 - Present

company logo

Vice President, Translational Medicine at

Syndax Pharmaceuticals

October 2005 - November 2013

company logo

Scientist at

Salk Institute for Biological Studies

February 2005 - October 2005

company logo

Research Scientist II at

X-Ceptor Therapeutics, Inc.

January 2000 - October 2004

company logo

Postdoctoral Fellow at

Salk Institute for Biological Studies

September 1997 - December 1999

Logos provided by Logo.dev

Peter Ordentlich

Education

University of Pennsylvania, Ph.D.

January 1991 - January 1997

University of Pennsylvania

January 1986 - January 1990

Frequently Asked Questions about Peter Ordentlich

What is Peter Ordentlich email address?

Peter Ordentlich's primary email address is ***********@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Peter Ordentlich work for?

Peter Ordentlich is a Chief Scientific Officer at Syndax Pharmaceuticals, a company specializing in Commercial physical research.

Where Peter Ordentlich graduated from?

Peter Ordentlich holds a degree in Immunology from University of Pennsylvania.

How can I directly contact Peter Ordentlich?

To contact Peter Ordentlich directly, you can use the email address ***********@syndax.com. Complete contact information is available upon registration with Muraena.

Who is Peter Ordentlich?

Peter Ordentlich is a seasoned scientific leader currently serving as the Chief Scientific Officer at Syndax Pharmaceuticals, a role he has held since November 2013. With a Ph.D. in Immunology from the University of Pennsylvania, he has built a robust career in the scientific research and development sector, contributing significantly to the field of translational medicine. Prior to his current position, Peter held various roles at Syndax and the Salk Institute, where he honed his expertise in drug development and research methodologies. His career reflects a deep commitment to advancing scientific knowledge and innovation. Peter's experience spans over two decades, showcasing his ability to lead complex research initiatives in both academic and corporate environments. He is known for his strategic vision and collaborative approach, which have been instrumental in driving scientific advancements. Outside of his professional endeavors, Peter is passionate about mentoring the next generation of scientists and fostering a culture of innovation in the pharmaceutical industry.

Peter`s contact details

mail

***********@syndax.com

Colleagues

Gloria Lee

VP, clinical development

avatar
Rebecca Bagley

Executive Director, Clinical Sciences, Revumenib Lead

avatar
Michelle Busa

Executive Director, Clinical Data Management

avatar
Soujanya Sunkaraneni

Executive Director, Head of DMPK & Clinical pharmacology

avatar
Shaliny Kushwaha

Vice President Regulatory Affairs and QA

avatar
Sharon Klahre

Vice President, Investor Relations and Corporate Communications

Tyson Kamikawa

Vice President Information Technology

avatar
Deirdre Vitale

Vice President, Talent and Experience

View Contact details (it's free)
Request Profile Removal